4//SEC Filing
Kelbon Marcia S. 4
Accession 0000899243-18-020780
CIK 0001285819other
Filed
Jul 29, 8:00 PM ET
Accepted
Jul 30, 7:00 PM ET
Size
19.2 KB
Accession
0000899243-18-020780
Insider Transaction Report
Form 4
OMEROS CORPOMER
Kelbon Marcia S.
VP, Patent & Gen Cnsl, Sec.
Transactions
- Exercise/Conversion
Common Stock
2018-07-26$6.05/sh+8,000$48,400→ 192,645 total - Sale
Common Stock
2018-07-27$21.73/sh−5,723$124,357→ 192,645 total - Exercise/Conversion
Stock Option (Right to Buy)
2018-07-26−8,000→ 61,996 totalExercise: $6.05Exp: 2020-03-28→ Common Stock (8,000 underlying) - Sale
Common Stock
2018-07-26$21.53/sh−35,000$753,687→ 184,645 total - Exercise/Conversion
Common Stock
2018-07-27$4.10/sh+5,723$23,464→ 198,368 total - Exercise/Conversion
Common Stock
2018-07-26$4.10/sh+35,000$143,500→ 219,645 total - Exercise/Conversion
Stock Option (Right to Buy)
2018-07-26−35,000→ 48,252 totalExercise: $4.10Exp: 2022-01-07→ Common Stock (35,000 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2018-07-27−5,723→ 42,529 totalExercise: $4.10Exp: 2022-01-07→ Common Stock (35,000 underlying)
Footnotes (5)
- [F1]Open market sale pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. The trading schedule, including sale periods, price and the number of shares to be sold, was established in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The sale was planned in advance for purposes including funding ongoing home construction and the exercise and holding of certain Omeros options.
- [F2]This transaction was executed in multiple trades at prices ranging from $21.45 to $21.63; the price reported above reflects the weighted average sales price. The reporting person undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.
- [F3]This transaction was executed in multiple trades at prices ranging from $21.48 to $21.90; the price reported above reflects the weighted average sales price. The reporting person undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.
- [F4]The option vested and became exercisable over 48 equal monthly installments, with a vesting commencement date of April 1, 2011.
- [F5]On July 26, 2018, the reporting person paid the exercise price and exercised options to purchase 8,000 shares of the company's common stock. The shares have not been sold and are held for the account of the reporting person. The options previously vested and became exercisable in 48 equal monthly installments, with a vesting commencement date of April 1, 2010.
Documents
Issuer
OMEROS CORP
CIK 0001285819
Entity typeother
Related Parties
1- filerCIK 0001472163
Filing Metadata
- Form type
- 4
- Filed
- Jul 29, 8:00 PM ET
- Accepted
- Jul 30, 7:00 PM ET
- Size
- 19.2 KB